|
?:authorAffiliation
|
-
[\'Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.\', \'Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.\', \'Radboud University Medical Center, Nijmegen, The Netherlands.\', \'Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent, Belgium.\', \'Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.\', \'Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.\', \'Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.\', \'Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.\', \'Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.\', \'Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D\'Investigacions Mèdiques (IMIM), Barcelona, Spain.\', \'Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol, UK.\', \'St. Vincent\'s Hospital, Darlinghurst, NSW, Australia.\', \'University of New South Wales, Sydney, NSW, Australia.\', \'HaaglandenMC, The Hague and ErasmusMC, Rotterdam, The Netherlands.\', \'Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.\', \'Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.\', \'University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.\', \'Department of Infectious Diseases, Royal Brisbane and Women\'s Hospital, Brisbane, QLD, Australia.\', \'Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, UK.\', \'Department of Pharmacy, Great Ormond Street Hospital for Children, London, UK.\', \'Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil.\', \'Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.\', \'Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris, France.\', \'EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris, France.\', \'University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.\', \'Department of Pharmacy, Royal Brisbane and Women\'s Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.\', \'Department of Intensive Care Medicine, Royal Brisbane and Women\'s Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.\', \'Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France. j.roberts2@uq.edu.au.\', \'The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women\'s Hospital, Butterfield St, Herston, QLD, 4029, Australia. j.roberts2@uq.edu.au.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}